Jobs / United States / Glaxosmithkline LLC
Senior Director, R&D AI & Technology Adoption
Glaxosmithkline LLC · 🇺🇸 5 Locations
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Glaxosmithkline LLC paid sponsored hires in similar roles1 certified filing for “Product Director, Platform API” (Information Technology Project Managers) in TX: $149k–$149k, median $149k. Most were filed at wage level IV (100%) — 4 lottery entries, ≈61% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Glaxosmithkline LLC
The US Department of Labor certified 39 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 15 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Glaxosmithkline LLC →
About the role
We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme. We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work. Discover more about our company wide benefits and life at GSK on our webpage Life at GSK | GSK Senior Director, R&D AI & Technology Adoption R&D Tech Transformation & Operations connects strategy, investment and delivery across priority R&D technology programmes. The team works with scientific, technology and business leaders to strengthen decisions, accelerate value and support consistent adoption across R&D. This role will shape how R&D adopts AI and technology so that new capabilities deliver measurable value and lasting changes in how people work. You will help establish and may lead a small, hands-on R&D technology adoption capability.. The role combines strategic leadership with direct delivery, including cross-R&D initiatives, practical adoption methods and evidence-based value measurement. You will also help establish a hub-and-spoke model that enables local teams to adapt change approaches to their scientific context. For candidates seeking to be located at our Stevenage site, this role will temporarily be based at Stevenage. However, the Company plans to relocate its offices to Cambridge, UK. The location of this role will therefore subsequently change to Cambridge, UK in accordance with timelines to be set by the Company. The relocation is currently proposed to take effect by early 2029. In this role you will • Shape and lead the R&D approach to AI and technology adoption, connecting behaviour and process change with measurable value. • Build and lead a small internal adoption capability while remaining a hands-on contributor to priority projects. • Establish a hub-and-spoke model that coordinates cross-R&D adoption while enabling departments to address local needs. • Partner with priority technology programmes to assess adoption plans, identify gaps and ensure capable delivery teams are in place. • Lead adoption for technologies and ways of working that span R&D, including enterprise productivity tools, data platforms and major cross-R&D transformation programmes. • Define clear adoption roadmaps covering stakeholder alignment, readiness, communications, capability building, process change and reinforcement. • Develop practical, reusable methods and tools that improve consistency without creating unnecessary bureaucracy. • Define measures that connect adoption, behaviour and process change to programme outcomes and value. • Advise on the right balance of internal capability and external consulting support, and strengthen internal ownership over time. • Influence senior R&D, scientific and technology leaders, keeping adoption and change visible in portfolio and investment decisions. • Support adjacent strategic work when required, applying analytical and project leadership skills beyond a narrow change-management remit. Why you? Basic qualifications We are looking for professionals with these required skills to achieve our goals: • Extensive experience leading enterprise technology adoption, organisational change or digital transformation in a large pharmaceutical R&D environment. • Demonstrated delivery of AI, digital tools, data platforms, or technology adoption and behaviour change, not solely advisory or methodology development. • Experience creating and executing change strategies across multiple functions, business areas or geographies. • Str